Johnson & Johnson

Johnson & Johnson Announces Start of Phase 3 Trials for CCP Virus Vaccine

U.S. company Johnson & Johnson on Wednesday announced it has reached phase 3 clinical trials for its CCP virus vaccine candidate, becoming the fourth manufacturer to reach this phase in clinical trials amid a global pandemic. The company joins Moderna, Pfizer, and AstraZeneca to start…
0

Brazil approves final tests of J&J virus vaccine

Brazilian health regulators said Tuesday they had approved Johnson & Johnson’s experimental vaccine against the new coronavirus for the final stage of clinical trials, the fourth vaccine to receive widespread testing in the hard-hit country. The US pharmaceutical company’s subsidiary Janssen will test the vaccine…